The committee that advises the California Division of Workers’ Compensation on evidence-based updates to the prescription drug formulary is meeting virtually Oct. 18.
Members of the Pharmacy and Therapeutics Committee will discuss the formulary drug list in the Medical Treatment Utilization Schedule, as well as issues relating to prescription painkillers.
Members will also discuss guidelines that the Medical Board of California issued in July for prescribing controlled substances to treat pain. The guidance includes a section on workers’ comp patients, which “presents its o...
Comments